Premium
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience
Author(s) -
JurgensenRauch Amanda,
Gibbs Suzanne,
Farrell Maresa,
Aries James,
Grantham Marianne,
Eccersley Lydia,
Gribben John,
Hallam Simon,
Oakervee Heather,
Cavenagh Jamie,
Davies Jeff,
Sive Jonathan
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17379
Subject(s) - medicine , fludarabine , multiple myeloma , cyclophosphamide , melphalan , transplantation , surgery , hematopoietic stem cell transplantation , oncology , regimen , gastroenterology , chemotherapy